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In the article by Brott TG, Halperin JL, Abbara S, et al. “2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/
SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral
Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American
Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of
Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and
Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine,
and Society for Vascular Surgery,” which appeared in the February 22, 2011, issue of the Journal (J Am Coll Cardiol
2011;57:e16–94; doi:10.1016/j.jacc.2010.11.006), the following corrections were necessary:
In Section 11.2.1, “Recommendations for Management of Patients With Cervical Artery Dissection,” the Class IIa
Recommendation #1 (p. e67), which began “For patients with symptomatic cervical artery dissection, anticoagulation
with. . .,” has been changed to read:
1. Antithrombotic treatment with either an anticoagulant (heparin, low molecular weight heparin, or warfarin*) or a
platelet inhibitor (aspirin, clopidogrel, or the combination of extended-release dipyridamole plus aspirin*) for at least 3 to
6 months is reasonable for patients with extracranial carotid or vertebral arterial dissection associated with ischemic stroke
or TIA (724a–724d). (Level of Evidence: B)
*Drugs are not listed in order of preference.
The following references were added to the reference list:
724a. Metso TM, Metso AJ, Helenius J, et al. Prognosis and safety of anticoagulation in intracranial artery dissections
in adults. Stroke. 2007;38:1837–42.
724b. Engelter ST, Brandt T, Debette S, et al., for the Cervical Artery Dissection in Ischemic Stroke Patients (CADISP)
Study Group. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke. 2007;38:2605–11.
724c. Menon R, Kerry S, Norris JW, Markus HS. Treatment of cervical artery dissection: a systematic review and
meta-analysis. J Neurol Neurosurg Psychiatry. 2008;79:1122–7.
724d. Georgiadis D, Arnold M, von Buedingen HC, et al. Aspirin vs anticoagulation in carotid artery dissection: a study
of 298 patients. Neurology. 2009;72:1810–5.
This article is e-only content, and the updated version is available at: http://content.onlinejacc.org/cgi/content/full/57/8/e16.
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